Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
Welgen Incorporation
Download detailed PDF Members: Welgen, Inc. was founded in 2002 to provide the fastest, most reliable technology available for the construction of recombinant adenoviruses and other research tools. We are currently located in a facility managed by the Massachusetts Biomedical Initiative to foster the development of new biotechnology companies in Massachusetts. We are located in Worcester, the second largest city in New England, and only a 40 min drive from Boston. Welgen offers an improved technology to simplify and accelerate the construction of adenoviral vectors, which offer many advantages to investigators who study gene expression or gene silencing in mammalian systems. Adenoviruses have a strong safety record and recombinant adenoviral vectors have been useful tools for gene function studies as well as for human gene therapy. Recombinant adenoviruses that cannot replicate are attractive vectors for gene delivery for several reasons:they infect many types of mammalian cells with high efficiency
This page has been viewed 517 times since April 2007, the link to the organisation's website has been followed 92 times Recent Search Terms used to find this page: welgen | welgen | welgen | welgen | welgen | welgen | welgen | welgen | welgen | . Search for more companies in Worcester Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Welgen Incorporation | ||||||||||||||||||||||||||
|